Sandu Pharmaceuticals Share Price

Sandu Pharmaceuticals Corporate Action

CMP as on12-Aug-22 15:56

₹ 66.50
0.5 0.76%

Open

₹ 67.50

Turnover (lac)

₹ 2

Prev. Close

₹ 66.00

Day's Vol (shares)

₹ 2,035

Day's Range

₹ 66.20
₹ 68.00

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 30-Jul-2022 - -
SANDU PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022 inter alia to consider and approve 1. To Approve Unaudited Financial Results of the Company for the Quarter 30th June 2022. 2. To consider/recommend Dividend for the Financial Year 2021-22. 3. Any other matter with the permission of Chairman. Compliance of Reg 29(1)(e) of SEBI (LODR) Regulation 2015-Board to consider Dividend (As Per BSE Announcement Dated on 30/07/2022) Outcome of the Board Meeting (As Per BSE Announcement Dated on 12.08.2022)
Board Meeting - 02-Jul-2022 - -
SANDU PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/07/2022 inter alia to consider and approve 1. To Consider and Reappoint CMA Shekhar Joshi & Co Cost Accountants (Registration No. 100448) as Cost Auditor of the Company for the Financial Year 2022-23. 2. To Consider/Approve/Discuss on 03RD and Final Tranche conversion of 850326 nos of Equity Warrants Conversion into Equity Shares. 3. Any other matter. Outcome of the Board Meeting dated 07th July 2022 (As per BSE Announcement Dated on 07/07/2022)
Board Meeting - 15-May-2022 - -
SANDU PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 inter alia to consider and approve 1.Approval of audited financial results for quarter and year ended 31st march 2022 2.any other item with permission of Chairman Outcome of the Board Meeting dated 30th May 2022 (As Per BSE Announcement Dated on 30/05/2022)
Board Meeting - 05-Feb-2022 - -
SANDU PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 inter alia to consider and approve 1.Approval of Unaudited Financial Results for the Q ended 31st December 2021. 2.Appointment of Chairman of the Company 3.Any other matter 1. Appointment of Shri K Vinay Kumar, Independent Director(DIN: 02322747) as Chairman of the Company. 2. Approved Un-audited Financial Results for the Quarter ended 31st December 2021. 3. Approved and took decision on conversion of the 02nd Tranch of 8,89,667 nos of Equity warrants into Equity Shares at Rs 20.69 per Shares as per the sanction given by BSE dated 26th March 2021 asking the allottees to bring 02nd Tranche subscription money. 4. Consider and Approved incorporating a wholly owned Subsidiary Company of Sandu Pharmaceuticals Limited. Unaudited Financial Results for Q ended 31st December 2021 (As per BSE Announcement Dated on 14/02/2022)
Board Meeting - 25-Nov-2021 - -
Inter alia, to consider and approve Appointment of Internal Auditor for Mumbai at its Corporate Office Outcome of the Board Meeting dated 29.11.2021 (As Per BSE Announcement dated on 29.11.2021)
Board Meeting - 01-Nov-2021 - -
Quarterly Results SANDU PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2021 ,inter alia, to consider and approve 1. approval of Unaudited Financial Results for Q ended 30th September 2021. 2.Any other matter with permission of chairman (As per BSE Announcement Dated on 30/10/2021) Outcome of the Board Meeting dated 13.11.2021 (As Per BSE Announcement dated on 13.11.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity